Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
GO_Biological_Process_2021,Ribosome,41/158,1.238357829522012e-18,3.368333296299873e-16,0,0,6.862414441252615,282.9561881923349,RPL30;RPL3;RPL32;RPL10;RPL31;RPL34;RPLP1;RPL12;RPL11;RPL10A;RPS15;RPS14;RPS16;RPS18;RPL14;RPLP2;RPL13;RPL38;RPL37;RPL15;RPS2;RPS11;RPS27A;RPS12;RPL19;RPS9;RPS8;RPL23;RPL13A;RPL35A;RPL23A;MRPS7;MRPS18C;RPS25;RPS28;RPS27;RPL27A;FAU;RPL29;RPS24;RPS23
GO_Biological_Process_2021,Coronavirus disease,44/232,1.8767833569841293e-14,2.552425365498416e-12,0,0,4.580268780304205,144.7668696664244,RPL30;RPL3;RPL32;RPL10;RPL31;RPL34;RPLP1;RPL12;RPL11;F13A1;RPL10A;RPS15;RPS14;RPS16;RPS18;RPL14;RPLP2;RPL13;MAPK1;RPL38;RPL37;RPL15;RPS2;RPS11;RPS27A;RPS12;RPL19;JUN;RPS9;RPS8;RPL23;MX1;RPL13A;RPL35A;RPL23A;RPS25;MAPK11;RPS28;RPS27;RPL27A;FAU;RPL29;RPS24;RPS23
GO_Biological_Process_2021,Prion disease,24/273,0.0057234198201058,0.4372515594110442,0,0,1.841838301217101,9.509758854357964,NDUFA12;NDUFB11;COX4I1;NDUFB2;NDUFA1;ITPR2;COX7A2;NDUFC1;CACNA1C;TUBB4B;ATP5F1E;SEM1;CREB3;MAPK11;TUBB2A;UQCRQ;CREB3L1;NDUFS5;PPIF;VDAC2;MAPK1;NCAM2;TUBA8;SLC25A6
GO_Biological_Process_2021,Huntington disease,26/306,0.0064301699913388,0.4372515594110442,0,0,1.7750984970086094,8.958485979553341,HIP1;NDUFA12;NDUFB11;COX4I1;NDUFB2;AP2A1;COX7A2;CREB3L1;POLR2G;POLR2I;MAP3K5;DNAH17;NDUFA1;NDUFC1;TUBB4B;ATP5F1E;SEM1;CREB3;TUBB2A;UQCRQ;NDUFS5;PPIF;TFAM;VDAC2;TUBA8;SLC25A6
GO_Biological_Process_2021,"Parathyroid hormone synthesis, secretion and action",11/106,0.0175004057923628,0.7047515158948855,0,0,2.201630837657524,8.90676626705254,CREB3;MEF2C;MMP24;MMP16;NACA;CREB3L1;PDE4D;PDE4B;ITPR2;MAPK1;PLD1
GO_Biological_Process_2021,Fanconi anemia pathway,7/54,0.0178879026099246,0.7047515158948855,0,0,2.8276979490896688,11.377612070336747,FANCI;RMI1;RPA1;FANCC;FANCB;FAN1;ATR
GO_Biological_Process_2021,Spliceosome,14/150,0.0190081926296,0.7047515158948855,0,0,1.9589986347717692,7.763286699927227,DDX5;SF3B3;RBM8A;LSM5;CRNKL1;PRPF8;CDC40;PRPF6;PRPF18;SNRNP27;SNRPA1;SRSF5;SRSF7;SRSF10
GO_Biological_Process_2021,Non-alcoholic fatty liver disease,14/155,0.0244682094030332,0.7047515158948855,0,0,1.889029635513952,7.009018873517775,JUN;TGFB1;IRS1;NDUFA12;NDUFB11;COX4I1;NDUFB2;NDUFA1;COX7A2;NDUFC1;MAPK11;UQCRQ;NDUFS5;MAP3K5
GO_Biological_Process_2021,Thermogenesis,19/232,0.02527573561187,0.7047515158948855,0,0,1.699178165681037,6.249425064295115,NDUFA12;NDUFB11;COX18;COX4I1;NDUFB2;NDUFA1;COX7A2;NDUFC1;ARID1A;ATP5F1E;CREB3;MAPK11;UQCRQ;CREB3L1;NDUFS5;DPF1;ZNF516;COA6;MAP3K5
GO_Biological_Process_2021,Parkinson disease,20/249,0.0265682384427567,0.7047515158948855,0,0,1.663910624431982,6.036732338678938,NDUFA12;NDUFB11;COX4I1;NDUFB2;NDUFA1;ITPR2;COX7A2;NDUFC1;TUBB4B;ATP5F1E;SEM1;TUBB2A;UQCRQ;NDUFS5;PPIF;VDAC2;RPS27A;MAP3K5;TUBA8;SLC25A6
GO_Biological_Process_2021,Amyotrophic lateral sclerosis,27/364,0.0285009804222196,0.7047515158948855,0,0,1.5284811854872475,5.438056027248297,NDUFA12;NDUFB11;COX4I1;NDUFB2;COX7A2;HDAC6;ERBB4;NEFM;MAP3K5;GABARAPL2;DNAH17;NUP155;NDUFA1;NDUFC1;TUBB4B;ATP5F1E;SEM1;MAPK11;TUBB2A;NRG3;UQCRQ;VAPB;NDUFS5;HNRNPA2B1;SRSF7;PFN2;TUBA8
GO_Biological_Process_2021,Retrograde endocannabinoid signaling,13/148,0.0357757664402719,0.8109173726461641,0,0,1.830794504181601,6.097432773533446,KCNJ6;NDUFA12;NDUFB11;NDUFB2;NDUFA1;ITPR2;NDUFC1;CACNA1C;GABRG1;RIMS1;MAPK11;NDUFS5;MAPK1
GO_Biological_Process_2021,Diabetic cardiomyopathy,16/203,0.0504861068242275,0.9999956780977234,0,0,1.6271391726099391,4.858730467576847,TGFB1;IRS1;NDUFA12;NDUFB11;COX4I1;NDUFB2;NDUFA1;COX7A2;NDUFC1;ATP5F1E;MAPK11;UQCRQ;NDUFS5;PPIF;VDAC2;SLC25A6
GO_Biological_Process_2021,Ferroptosis,5/41,0.0532766319884567,0.9999956780977234,0,0,2.6331944444444444,7.721204074886839,FTH1;GSS;VDAC2;CP;FTL
GO_Biological_Process_2021,Glutathione metabolism,6/57,0.0655251605074753,0.9999956780977234,0,0,2.230936819172113,6.08001914191713,GSTM4;GSTK1;GSTM2;GSTO1;GSS;GSTT2
GO_Biological_Process_2021,RNA polymerase,4/31,0.0679638932394856,0.9999956780977234,0,0,2.8072668072668074,7.548119187048602,POLR3D;POLR2G;POLR3H;POLR2I
GO_Biological_Process_2021,Cell adhesion molecules,12/148,0.0696744946931462,0.9999956780977234,0,0,1.6757597298738227,4.464091464952034,NLGN1;NLGN4X;ITGA4;NEGR1;NRXN1;HLA-B;HLA-C;HLA-A;PDCD1LG2;NCAM2;HLA-F;LRRC4C
GO_Biological_Process_2021,Viral myocarditis,6/60,0.0798943772979899,0.9999956780977234,0,0,2.1066622177733287,5.323640336988906,SGCA;HLA-B;ABL1;HLA-C;HLA-A;HLA-F
GO_Biological_Process_2021,Alzheimer disease,25/369,0.0803158919894795,0.9999956780977234,0,0,1.3831128381585192,3.4879170396543056,CHRM3;IRS1;NDUFA12;NDUFB11;COX4I1;NDUFB2;ITPR2;COX7A2;CACNA1C;DVL1;MAPK1;MAP3K5;NDUFA1;ADAM10;NDUFC1;TUBB4B;ATP5F1E;SEM1;TUBB2A;UQCRQ;NDUFS5;PPIF;VDAC2;TUBA8;SLC25A6
GO_Biological_Process_2021,Human T-cell leukemia virus 1 infection,16/219,0.0861992259108917,0.9999956780977234,0,0,1.497616640184891,3.670799283120408,JUN;TGFB1;IL15;HLA-B;HLA-C;HLA-A;HLA-F;KAT2B;CREB3;CREB3L1;VDAC2;MAPK1;TLN2;B2M;ATR;SLC25A6
GO_Biological_Process_2021,Cellular senescence,12/156,0.0942821398223017,0.9999956780977234,0,0,1.5819906008727762,3.7358130687572126,MAPK11;TGFB1;HLA-B;HLA-C;VDAC2;ITPR2;MAPK1;HLA-A;BTRC;HLA-F;ATR;SLC25A6
GO_Biological_Process_2021,Antigen processing and presentation,7/78,0.0966483947210074,0.9999956780977234,0,0,1.869485449772785,4.368381189577849,CTSL;NFYC;HLA-B;HLA-C;HLA-A;HLA-F;B2M
GO_Biological_Process_2021,Oocyte meiosis,10/129,0.1148295013518544,0.9999956780977234,0,0,1.594189434567797,3.450315109755921,MAPK11;STAG3;SPDYA;SPDYE17;ITPR2;MAPK1;SPDYE3;SPDYE18;BTRC;SMC1A
GO_Biological_Process_2021,Pathways of neurodegeneration,30/475,0.1176901457521307,0.9999956780977234,0,0,1.282627484874676,2.744438018679294,CHRM3;HIP1;NDUFA12;NDUFB11;COX4I1;NDUFB2;ITPR2;COX7A2;CACNA1C;DVL1;MAPK1;NEFM;RPS27A;MAP3K5;GABARAPL2;DNAH17;NDUFA1;NDUFC1;TUBB4B;ATP5F1E;SEM1;MAPK11;TUBB2A;UQCRQ;VAPB;NDUFS5;PPIF;VDAC2;TUBA8;SLC25A6
GO_Biological_Process_2021,Allograft rejection,4/38,0.1218128601787754,0.9999956780977234,0,0,2.228477404947993,4.69154516641564,HLA-B;HLA-C;HLA-A;HLA-F
GO_Biological_Process_2021,Oxidative phosphorylation,10/133,0.1326382583693247,0.9999956780977234,0,0,1.542019038280835,3.1150784852459825,NDUFA12;NDUFB11;UQCRQ;COX4I1;NDUFS5;NDUFB2;NDUFA1;COX7A2;NDUFC1;ATP5F1E
GO_Biological_Process_2021,cGMP-PKG signaling pathway,12/167,0.1357399612810554,0.9999956780977234,0,0,1.468862683948933,2.9333397448496723,CREB3;MEF2C;IRS1;CREB3L1;PPIF;VDAC2;ITPR2;MAPK1;PDE5A;CACNA1C;ADRA1A;SLC25A6
GO_Biological_Process_2021,Graft-versus-host disease,4/42,0.1587007121022297,0.9999956780977234,0,0,1.99348020400652,3.669469110976817,HLA-B;HLA-C;HLA-A;HLA-F
GO_Biological_Process_2021,Type I diabetes mellitus,4/43,0.1685028561079632,0.9999956780977234,0,0,1.9422628653397884,3.4587867199605644,HLA-B;HLA-C;HLA-A;HLA-F
GO_Biological_Process_2021,Drug metabolism,8/108,0.1760788139664985,0.9999956780977234,0,0,1.516148445336008,2.6332823669278094,GSTM4;GSTK1;GSTM2;GSTO1;DPYD;GSTT2;NME3;FMO3
GO_Biological_Process_2021,Vasopressin-regulated water reabsorption,4/44,0.1785116330594728,0.9999956780977234,0,0,1.8936063936063936,3.2628760336777263,CREB3;DYNC1LI2;CREB3L1;RAB11A
GO_Biological_Process_2021,Metabolism of xenobiotics by cytochrome P450,6/76,0.1822965534915083,0.9999956780977234,0,0,1.6237666237666235,2.763846462680913,GSTM4;GSTK1;GSTM2;GSTO1;GSTT2;CBR3
GO_Biological_Process_2021,Arrhythmogenic right ventricular cardiomyopathy,6/77,0.189950660789077,0.9999956780977234,0,0,1.6008120796853191,2.658934329947072,TCF7L1;SGCA;ITGA4;PKP2;CACNA1C;EMD
GO_Biological_Process_2021,Leishmaniasis,6/77,0.189950660789077,0.9999956780977234,0,0,1.6008120796853191,2.658934329947072,MAPK11;JUN;TGFB1;ITGA4;IFNGR2;MAPK1
GO_Biological_Process_2021,TNF signaling pathway,8/112,0.2014770982878179,0.9999956780977234,0,0,1.4575264254301366,2.335073294625134,CREB3;MAPK11;JUN;IL15;CREB3L1;TAB3;MAPK1;MAP3K5
GO_Biological_Process_2021,Cholinergic synapse,8/113,0.2080473412364048,0.9999956780977234,0,0,1.4435688016430244,2.266388038781791,CHRM3;CREB3;KCNJ6;CREB3L1;KCNQ3;ITPR2;MAPK1;CACNA1C
GO_Biological_Process_2021,Wnt signaling pathway,11/166,0.2139659544392101,0.9999956780977234,0,0,1.3451028753164147,2.074065732387396,SFRP1;JUN;TCF7L1;DAAM1;TBL1XR1;RYK;DVL1;BTRC;LGR5;TLE6;RSPO4
GO_Biological_Process_2021,GnRH secretion,5/64,0.2182944145490762,0.9999956780977234,0,0,1.6047457627118644,2.442279589589694,TRPC5;KCNJ6;ITPR2;MAPK1;CACNA1C
GO_Biological_Process_2021,Cortisol synthesis and secretion,5/65,0.2275338384200189,0.9999956780977234,0,0,1.5779166666666666,2.3360366879417103,CREB3;CREB3L1;ITPR2;CACNA1C;PBX1
GO_Biological_Process_2021,Fructose and mannose metabolism,3/33,0.2293040456934698,0.9999956780977234,0,0,1.8927145708582835,2.787412948191968,PMM1;GMPPA;SORD
GO_Biological_Process_2021,Phagosome,10/152,0.234753875724143,0.9999956780977234,0,0,1.3343477953146012,1.9337603775736172,DYNC1LI2;TUBB2A;CTSL;HLA-B;M6PR;HLA-C;HLA-A;HLA-F;TUBB4B;TUBA8
GO_Biological_Process_2021,Cysteine and methionine metabolism,4/50,0.2421675823570781,0.9999956780977234,0,0,1.6460930373973852,2.3343661880945645,AHCYL2;GSS;APIP;BCAT2
GO_Biological_Process_2021,Protein digestion and absorption,7/103,0.2603079356161829,0.9999956780977234,0,0,1.380813710754843,1.85842333896311,CPA1;COL5A3;KCNJ13;COL7A1;SLC3A1;SLC16A10;COL9A3
GO_Biological_Process_2021,Fluid shear stress and atherosclerosis,9/139,0.2649506340135498,0.9999956780977234,0,0,1.31128359592215,1.7416622889840574,GSTM4;MAPK11;MEF2C;GSTM2;JUN;CTSL;GSTO1;GSTT2;MAP3K5
GO_Biological_Process_2021,"Phenylalanine, tyrosine and tryptophan biosynthesis",1/6,0.2660966895579181,0.9999956780977234,0,0,3.782868525896415,5.008122776157831,PAH
GO_Biological_Process_2021,Human immunodeficiency virus 1 infection,13/212,0.2694688455713109,0.9999956780977234,0,0,1.237781650186416,1.6231061675953755,JUN;HLA-B;HLA-C;ITPR2;HLA-A;HLA-F;MAPK11;TRIM5;MAPK1;ELOB;BTRC;B2M;ATR
GO_Biological_Process_2021,Autoimmune thyroid disease,4/53,0.2757215227380227,0.9999956780977234,0,0,1.545067177720239,1.9906087720845531,HLA-B;HLA-C;HLA-A;HLA-F
GO_Biological_Process_2021,Gap junction,6/88,0.2809696395653172,0.9999956780977234,0,0,1.3852633120925804,1.758603770717672,TUBB2A;PDGFC;ITPR2;MAPK1;TUBB4B;TUBA8
GO_Biological_Process_2021,Aldosterone-regulated sodium reabsorption,3/37,0.2841880226466651,0.9999956780977234,0,0,1.6696900317013033,2.1006691008031826,IRS1;MAPK1;SGK1
GO_Biological_Process_2021,Pantothenate and CoA biosynthesis,2/21,0.285009543725618,0.9999956780977234,0,0,1.991499186650575,2.4997947268860785,DPYD;BCAT2
GO_Biological_Process_2021,Apoptosis,9/142,0.2852676114848842,0.9999956780977234,0,0,1.2815019476401848,1.60742320038025,JUN;CTSL;PARP2;ITPR2;MAPK1;CTSV;LMNB2;MAP3K5;TUBA8
GO_Biological_Process_2021,Terpenoid backbone biosynthesis,2/22,0.3039293600649999,0.9999956780977234,0,0,1.8918245264207376,2.253087286499711,ICMT;PCYOX1
GO_Biological_Process_2021,Morphine addiction,6/91,0.3073900371560162,0.9999956780977234,0,0,1.3361596891008656,1.5761845541785693,KCNJ6;PDE4D;PDE4B;OPRM1;PDE7B;GABRG1
GO_Biological_Process_2021,Various types of N-glycan biosynthesis,3/39,0.3120595536487195,0.9999956780977234,0,0,1.5767631403858948,1.836237225825846,MAN2A2;ALG1;B4GALNT3
GO_Biological_Process_2021,Renin-angiotensin system,2/23,0.3227550145727728,0.9999956780977234,0,0,1.801642690974695,2.037408738571878,ATP6AP2;PREP
GO_Biological_Process_2021,Viral carcinogenesis,12/203,0.3233104988931906,0.9999956780977234,0,0,1.1897312601825345,1.343375678098134,KAT2B;CREB3;JUN;CREB3L1;HLA-B;HLA-C;MAPK1;HLA-A;HLA-F;H4C3;HDAC9;HDAC6
GO_Biological_Process_2021,GnRH signaling pathway,6/93,0.325236272234742,0.9999956780977234,0,0,1.3053053053053052,1.4661233168725898,MAPK11;JUN;ITPR2;MAPK1;CACNA1C;PLD1
GO_Biological_Process_2021,Toxoplasmosis,7/112,0.3324080375978966,0.9999956780977234,0,0,1.2618570474281896,1.389799302348066,MAPK11;TGFB1;IFNGR2;ALOX5;LAMA3;PPIF;MAPK1
GO_Biological_Process_2021,Proteoglycans in cancer,12/205,0.3353316501386825,0.9999956780977234,0,0,1.1772772098993471,1.286334562629479,VAV3;CD63;MAPK11;DDX5;TGFB1;HPSE2;CTSL;ERBB4;ITPR2;MAPK1;ESR1;CD44
GO_Biological_Process_2021,Hepatocellular carcinoma,10/168,0.3372490964285859,0.9999956780977234,0,0,1.1982062209783093,1.3023704373131966,GSTM4;GSTM2;TCF7L1;TGFB1;GSTO1;DPF1;DVL1;GSTT2;MAPK1;ARID1A
GO_Biological_Process_2021,Homologous recombination,3/41,0.3399958207173202,0.9999956780977234,0,0,1.4936180271036874,1.6113479177161392,BARD1;SEM1;RPA1
GO_Biological_Process_2021,Glutamatergic synapse,7/114,0.3488583040400032,0.9999956780977234,0,0,1.238139831063997,1.3038719873274234,HOMER1;ITPR2;MAPK1;CACNA1C;GRIK2;PLD1;SHANK2
GO_Biological_Process_2021,Shigellosis,14/246,0.3548284791009913,0.9999956780977234,0,0,1.1425327951564077,1.18380195230048,GABARAPL2;JUN;SEPTIN6;ITPR2;FNBP1L;MAPK11;RRAGA;TAB3;MAPK1;TLN2;BTRC;RPS27A;CD44;PFN2
GO_Biological_Process_2021,Choline metabolism in cancer,6/98,0.3703517245086584,0.9999956780977234,0,0,1.2340383862122992,1.2257729428465638,JUN;SLC44A1;DGKB;PDGFC;MAPK1;PLD1
GO_Biological_Process_2021,Kaposi sarcoma-associated herpesvirus infection,11/193,0.3780358622872826,0.9999956780977234,0,0,1.1439129281181597,1.1127598483305638,GABARAPL2;MAPK11;JUN;TCF7L1;HLA-B;HLA-C;ITPR2;MAPK1;HLA-A;HLA-F;RPS27A
GO_Biological_Process_2021,Estrogen signaling pathway,8/137,0.3834719771764942,0.9999956780977234,0,0,1.1735050111575036,1.1247913302484254,CREB3;JUN;KCNJ6;CREB3L1;ITPR2;MAPK1;OPRM1;ESR1
GO_Biological_Process_2021,Progesterone-mediated oocyte maturation,6/100,0.3884888271242804,0.9999956780977234,0,0,1.207654462973612,1.1418262671641912,MAPK11;SPDYA;SPDYE17;MAPK1;SPDYE3;SPDYE18
GO_Biological_Process_2021,Endocytosis,14/252,0.3886928216959152,0.9999956780977234,0,0,1.1133733008844304,1.052099813060062,ARFGEF2;SH3KBP1;HLA-B;HLA-C;AP2A1;HLA-A;ARAP1;HLA-F;PLD1;ARFGAP3;RAB11A;EPN1;ZFYVE27;SH3GL2
GO_Biological_Process_2021,"Growth hormone synthesis, secretion and action",7/119,0.3902875273861949,0.9999956780977234,0,0,1.182552605210421,1.112630116557626,CREB3;MAPK11;IRS1;CREB3L1;ITPR2;MAPK1;CACNA1C
GO_Biological_Process_2021,Neurotrophin signaling pathway,7/119,0.3902875273861949,0.9999956780977234,0,0,1.182552605210421,1.112630116557626,BEX3;MAPK11;JUN;IRS1;ABL1;MAPK1;MAP3K5
GO_Biological_Process_2021,Basal transcription factors,3/45,0.3954884455660265,0.9999956780977234,0,0,1.3510835471913316,1.253310639283045,TAF11;TAF7;TAF3
GO_Biological_Process_2021,Type II diabetes mellitus,3/46,0.4091901887537059,0.9999956780977234,0,0,1.3195933713967414,1.179155939590814,IRS1;MAPK1;CACNA1C
GO_Biological_Process_2021,ErbB signaling pathway,5/85,0.4254227267155362,0.9999956780977234,0,0,1.1821875,1.0103824997918118,JUN;NRG3;ERBB4;ABL1;MAPK1
GO_Biological_Process_2021,Axon guidance,10/182,0.4322825786620541,0.9999956780977234,0,0,1.0998597639359589,0.922425753445413,TRPC5;DPYSL5;DCC;RYK;SEMA3B;ABL1;MAPK1;UNC5C;LRRC4C;SRGAP1
GO_Biological_Process_2021,Colorectal cancer,5/86,0.4354085022520165,0.9999956780977234,0,0,1.1675308641975308,0.9707675915840028,JUN;TCF7L1;TGFB1;DCC;MAPK1
GO_Biological_Process_2021,Intestinal immune network for IgA production,3/48,0.4362917428022075,0.9999956780977234,0,0,1.2608117099135063,1.0457728649346685,TGFB1;ITGA4;IL15
GO_Biological_Process_2021,Fc epsilon RI signaling pathway,4/68,0.447825141434713,0.9999956780977234,0,0,1.1820054945054943,0.9495669887135596,VAV3;MAPK11;ALOX5;MAPK1
GO_Biological_Process_2021,Cocaine addiction,3/49,0.4496675964238533,0.9999956780977234,0,0,1.2333376724811247,0.9857409953853116,CREB3;JUN;CREB3L1
GO_Biological_Process_2021,Sphingolipid metabolism,3/49,0.4496675964238533,0.9999956780977234,0,0,1.2333376724811247,0.9857409953853116,SMPD4;SGMS1;ACER3
GO_Biological_Process_2021,ECM-receptor interaction,5/88,0.4552582410837276,0.9999956780977234,0,0,1.139277108433735,0.8964862858866259,ITGA4;LAMA3;TNC;COL9A3;CD44
GO_Biological_Process_2021,Amphetamine addiction,4/69,0.4590432470741363,0.9999956780977234,0,0,1.1637593176054717,0.9061156351478143,CREB3;JUN;CREB3L1;CACNA1C
GO_Biological_Process_2021,Renal cell carcinoma,4/69,0.4590432470741363,0.9999956780977234,0,0,1.1637593176054717,0.9061156351478143,JUN;TGFB1;MAPK1;ELOB
GO_Biological_Process_2021,RNA transport,10/186,0.4594857847210252,0.9999956780977234,0,0,1.0746345363179537,0.8356866177911177,PNN;EIF2B2;RBM8A;NUP155;EIF3H;SNORD3A;GEMIN8;RANGAP1;EIF1B;EIF1
GO_Biological_Process_2021,N-Glycan biosynthesis,3/50,0.4629122728993419,0.9999956780977234,0,0,1.207032743024589,0.929678005158909,ST6GAL2;MAN2A2;ALG1
GO_Biological_Process_2021,GABAergic synapse,5/89,0.465111550613,0.9999956780977234,0,0,1.125654761904762,0.8616639652587754,GABARAPL2;KCNJ6;PLCL1;CACNA1C;GABRG1
GO_Biological_Process_2021,Purine metabolism,7/129,0.4728559889473816,0.9999956780977234,0,0,1.0850471434672624,0.8126616827372946,PDE4D;PDE4B;NME3;ENPP4;PDE5A;PDE7B;FHIT
GO_Biological_Process_2021,Hypertrophic cardiomyopathy,5/90,0.4749103896745375,0.9999956780977234,0,0,1.1123529411764703,0.8282904207072713,TGFB1;SGCA;ITGA4;CACNA1C;EMD
GO_Biological_Process_2021,FoxO signaling pathway,7/131,0.4890902606326222,0.9999956780977234,0,0,1.067433253603982,0.7634370420499523,GABARAPL2;MAPK11;TGFB1;HOMER1;IRS1;MAPK1;SGK1
GO_Biological_Process_2021,Base excision repair,2/33,0.4991997862093132,0.9999956780977234,0,0,1.2198243977744188,0.8474716465848672,PARP2;APEX1
GO_Biological_Process_2021,Endocrine and other factor-regulated calcium reabsorption,3/53,0.5017641378233166,0.9999956780977234,0,0,1.1344311377245508,0.7823322034448827,AP2A1;ESR1;RAB11A
GO_Biological_Process_2021,Serotonergic synapse,6/113,0.5046091236892958,0.9999956780977234,0,0,1.060200387303191,0.7251464907564803,KCNJ6;KCND2;ALOX5;ITPR2;MAPK1;CACNA1C
GO_Biological_Process_2021,Pentose and glucuronate interconversions,2/34,0.5152209097902687,0.9999956780977234,0,0,1.1816425722831505,0.7836175201518081,AKR1A1;SORD
GO_Biological_Process_2021,Cushing syndrome,8/155,0.520515590619945,0.9999956780977234,0,0,1.0288279805402605,0.6717582483223027,CREB3;TCF7L1;CREB3L1;DVL1;ITPR2;MAPK1;CACNA1C;PBX1
GO_Biological_Process_2021,Thyroid hormone synthesis,4/75,0.5244707020667547,0.9999956780977234,0,0,1.0650757693011217,0.6873633816478254,CREB3;DUOX1;CREB3L1;ITPR2
GO_Biological_Process_2021,Dilated cardiomyopathy,5/96,0.532304100097696,0.9999956780977234,0,0,1.0386813186813186,0.6549304679130971,TGFB1;SGCA;ITGA4;CACNA1C;EMD
GO_Biological_Process_2021,Pancreatic cancer,4/76,0.5350081187657469,0.9999956780977234,0,0,1.0502275502275502,0.656889351389803,TGFB1;MAPK1;PLD1;ARHGEF6
GO_Biological_Process_2021,Autophagy,7/137,0.536805990555738,0.9999956780977234,0,0,1.017843379065824,0.6332192304528182,GABARAPL2;RRAGA;IRS1;CTSL;DAPK2;MAPK1;ATG4A
GO_Biological_Process_2021,Prostate cancer,5/97,0.5415982035409109,0.9999956780977234,0,0,1.0273369565217392,0.6299947400872264,CREB3;TCF7L1;CREB3L1;PDGFC;MAPK1
GO_Biological_Process_2021,Aldosterone synthesis and secretion,5/98,0.5508049984805251,0.9999956780977234,0,0,1.016236559139785,0.6060575060417436,CREB3;CREB3L1;ITPR2;CACNA1C;CAMK1
GO_Biological_Process_2021,Thyroid cancer,2/37,0.5611996272332626,0.9999956780977234,0,0,1.0801880074063523,0.6240014904387823,TCF7L1;MAPK1
GO_Biological_Process_2021,AMPK signaling pathway,6/120,0.5638650571297947,0.9999956780977234,0,0,0.994731573678942,0.5699218226756343,CREB3;IRS1;CREB3L1;SCD5;ADRA1A;ACACA
GO_Biological_Process_2021,Notch signaling pathway,3/59,0.5748245221945423,0.9999956780977234,0,0,1.0125641573994868,0.5606471176880907,KAT2B;DVL1;TLE6
GO_Biological_Process_2021,Melanogenesis,5/101,0.5778704420661342,0.9999956780977234,0,0,0.9843229166666668,0.5398081840667891,CREB3;TCF7L1;CREB3L1;DVL1;MAPK1
GO_Biological_Process_2021,Phenylalanine metabolism,1/17,0.5838953415354797,0.9999956780977234,0,0,1.181461653386454,0.6356659743771519,PAH
GO_Biological_Process_2021,Long-term depression,3/60,0.5863335038003683,0.9999956780977234,0,0,0.9947473474104422,0.5310623167560047,GRID2;ITPR2;MAPK1
GO_Biological_Process_2021,Mineral absorption,3/60,0.5863335038003683,0.9999956780977234,0,0,0.9947473474104422,0.5310623167560047,FTH1;FTL;MT1E
GO_Biological_Process_2021,Chagas disease,5/102,0.5866978638226888,0.9999956780977234,0,0,0.974123711340206,0.5194468946470295,MAPK11;JUN;TGFB1;IFNGR2;MAPK1
GO_Biological_Process_2021,Salmonella infection,12/249,0.6008392339032556,0.9999956780977234,0,0,0.9564674238657948,0.4872511700165519,MAPK11;DYNC1LI2;JUN;TCF7L1;TUBB2A;M6PR;TAB3;MAPK1;TUBB4B;PFN2;STX10;TUBA8
GO_Biological_Process_2021,Fatty acid biosynthesis,1/18,0.6048223268671755,0.9999956780977234,0,0,1.1119053198968831,0.559088831913749,ACACA
GO_Biological_Process_2021,Neutrophil extracellular trap formation,9/189,0.6134796705757332,0.9999956780977234,0,0,0.9445281124497992,0.4615041357024548,H2AZ1;MAPK11;PPIF;VDAC2;MAPK1;H4C3;HDAC9;HDAC6;SLC25A6
GO_Biological_Process_2021,Bladder cancer,2/41,0.6175071937116607,0.9999956780977234,0,0,0.9691949791650688,0.4672145519727722,DAPK2;MAPK1
GO_Biological_Process_2021,Glycosaminoglycan degradation,1/19,0.6246978300437082,0.9999956780977234,0,0,1.050077467906153,0.4940480266499983,HPSE2
GO_Biological_Process_2021,Th17 cell differentiation,5/107,0.6292705226180216,0.9999956780977234,0,0,0.9261274509803922,0.4289767073205927,MAPK11;JUN;TGFB1;IFNGR2;MAPK1
GO_Biological_Process_2021,Adrenergic signaling in cardiomyocytes,7/150,0.6331255234123102,0.9999956780977234,0,0,0.9246745238729208,0.4226563132031552,CREB3;MAPK11;CREB3L1;CREM;MAPK1;CACNA1C;ADRA1A
GO_Biological_Process_2021,Insulin secretion,4/86,0.6332948996733948,0.9999956780977234,0,0,0.9216637021515072,0.4210335728395842,CHRM3;CREB3;CREB3L1;CACNA1C
GO_Biological_Process_2021,Relaxin signaling pathway,6/129,0.634658555462412,0.9999956780977234,0,0,0.9215068727263848,0.4189798090368868,CREB3;MAPK11;JUN;TGFB1;CREB3L1;MAPK1
GO_Biological_Process_2021,Ribosome biogenesis in eukaryotes,5/108,0.6374586507969924,0.9999956780977234,0,0,0.9170873786407768,0.4129331423268976,RBM28;NOP58;GAR1;SNORD3A;NOP10
GO_Biological_Process_2021,Inflammatory bowel disease,3/65,0.6408086148249885,0.9999956780977234,0,0,0.9142843345566932,0.4068788734923605,JUN;TGFB1;IFNGR2
GO_Biological_Process_2021,Cardiac muscle contraction,4/87,0.6423522138945462,0.9999956780977234,0,0,0.9105111755714166,0.4030090961872501,UQCRQ;COX4I1;COX7A2;CACNA1C
GO_Biological_Process_2021,Natural killer cell mediated cytotoxicity,6/131,0.6494382804816042,0.9999956780977234,0,0,0.9066666666666666,0.3913603760540823,VAV3;IFNGR2;HLA-B;HLA-C;MAPK1;HLA-A
GO_Biological_Process_2021,Dopaminergic synapse,6/132,0.6566899812860659,0.9999956780977234,0,0,0.8994232327565661,0.3782463622802786,CREB3;MAPK11;KCNJ6;CREB3L1;ITPR2;CACNA1C
GO_Biological_Process_2021,PD-L1 expression and PD-1 checkpoint pathway in cancer,4/89,0.6600214311971034,0.9999956780977234,0,0,0.8889933595815949,0.3693616039967422,MAPK11;JUN;IFNGR2;MAPK1
GO_Biological_Process_2021,Oxytocin signaling pathway,7/154,0.6603628074493638,0.9999956780977234,0,0,0.8993224544326749,0.3731881397682099,MEF2C;JUN;KCNJ6;ITPR2;MAPK1;CACNA1C;CAMK1
GO_Biological_Process_2021,Chemical carcinogenesis,11/239,0.660496108218632,0.9999956780977234,0,0,0.9108907832962688,0.3778047478478722,GSTM4;GSTK1;CREB3;GSTM2;JUN;GSTO1;CREB3L1;GSTT2;MAPK1;CACNA1C;ESR1
GO_Biological_Process_2021,Long-term potentiation,3/67,0.6611332647874292,0.9999956780977234,0,0,0.8856193862275449,0.3664691679183652,ITPR2;MAPK1;CACNA1C
GO_Biological_Process_2021,Pathogenic Escherichia coli infection,9/197,0.6624382315833501,0.9999956780977234,0,0,0.903950910023071,0.3722722599510605,MAPK11;JUN;TUBB2A;ABL1;TAB3;MAPK1;TUBB4B;SEC24D;TUBA8
GO_Biological_Process_2021,Calcium signaling pathway,11/240,0.6658480130352799,0.9999956780977234,0,0,0.9068647694024408,0.368816318277493,CHRM3;STIM2;ERBB4;PDGFC;PPIF;VDAC2;ITPR2;CAMK1;CACNA1C;ADRA1A;SLC25A6
GO_Biological_Process_2021,Mitophagy,3/68,0.6709782462287183,0.9999956780977234,0,0,0.8719484108705665,0.3479236014478082,GABARAPL2;JUN;RPS27A
GO_Biological_Process_2021,Arginine biosynthesis,1/22,0.6785301639711308,0.9999956780977234,0,0,0.8999241130715234,0.3490142785129484,ARG2
GO_Biological_Process_2021,Proteasome,2/46,0.6798572230122992,0.9999956780977234,0,0,0.8588325931297018,0.3313998531826707,SEM1;PSMB9
GO_Biological_Process_2021,Th1 and Th2 cell differentiation,4/92,0.6853976144894467,0.9999956780977234,0,0,0.8585505403687221,0.3243227467208016,MAPK11;JUN;IFNGR2;MAPK1
GO_Biological_Process_2021,Focal adhesion,9/201,0.6855093186243785,0.9999956780977234,0,0,0.8849303463855421,0.3341436690245006,VAV3;JUN;ITGA4;PDGFC;LAMA3;TNC;MAPK1;COL9A3;TLN2
GO_Biological_Process_2021,Epithelial cell signaling in Helicobacter pylori infection,3/70,0.6900338490139599,0.9999956780977234,0,0,0.8458307266064885,0.3138155707352772,MAPK11;JUN;ADAM10
GO_Biological_Process_2021,Prolactin signaling pathway,3/70,0.6900338490139599,0.9999956780977234,0,0,0.8458307266064885,0.3138155707352772,MAPK11;MAPK1;ESR1
GO_Biological_Process_2021,RIG-I-like receptor signaling pathway,3/70,0.6900338490139599,0.9999956780977234,0,0,0.8458307266064885,0.3138155707352772,MAPK11;TRIM25;AZI2
GO_Biological_Process_2021,Epstein-Barr virus infection,9/202,0.6911232018357952,0.9999956780977234,0,0,0.8802983956551595,0.3252149534342049,SEM1;MAPK11;JUN;HLA-B;HLA-C;HLA-A;HLA-F;B2M;CD44
GO_Biological_Process_2021,Other types of O-glycan biosynthesis,2/47,0.691282180209076,0.9999956780977234,0,0,0.8397031128835715,0.3100244129551883,GALNT7;ST6GAL2
GO_Biological_Process_2021,Pyruvate metabolism,2/47,0.691282180209076,0.9999956780977234,0,0,0.8397031128835715,0.3100244129551883,AKR1A1;ACACA
GO_Biological_Process_2021,Rheumatoid arthritis,4/93,0.6935533226947757,0.9999956780977234,0,0,0.848859006162377,0.310620559366722,JUN;TGFB1;CTSL;IL15
GO_Biological_Process_2021,NOD-like receptor signaling pathway,8/181,0.6944302563955769,0.9999956780977234,0,0,0.8730005044033836,0.318351458361968,GABARAPL2;MAPK11;JUN;VDAC2;ITPR2;TAB3;MAPK1;SUGT1
GO_Biological_Process_2021,Mannose type O-glycan biosynthesis,1/23,0.6947017444374548,0.9999956780977234,0,0,0.8589731981166244,0.3129004605258642,LARGE1
GO_Biological_Process_2021,Mismatch repair,1/23,0.6947017444374548,0.9999956780977234,0,0,0.8589731981166244,0.3129004605258642,RPA1
GO_Biological_Process_2021,Protein export,1/23,0.6947017444374548,0.9999956780977234,0,0,0.8589731981166244,0.3129004605258642,IMMP2L
GO_Biological_Process_2021,Human papillomavirus infection,15/331,0.6965251035212131,0.9999956780977234,0,0,0.8956175680859225,0.3239013867939559,TCF7L1;ITGA4;LAMA3;MX1;HLA-B;TNC;HLA-C;HLA-A;HLA-F;CREB3;CREB3L1;DVL1;MAPK1;COL9A3;ATR
GO_Biological_Process_2021,Human cytomegalovirus infection,10/225,0.6992087820492241,0.9999956780977234,0,0,0.8778777608975108,0.3141098375703819,CREB3;MAPK11;CREB3L1;HLA-B;HLA-C;ITPR2;MAPK1;HLA-A;HLA-F;B2M
GO_Biological_Process_2021,IL-17 signaling pathway,4/94,0.7015571173547086,0.9999956780977234,0,0,0.8393828393828394,0.297521732838843,MAPK11;JUN;MAPK1;TAB3
GO_Biological_Process_2021,Amino sugar and nucleotide sugar metabolism,2/48,0.7023687091634174,0.9999956780977234,0,0,0.8214053491698816,0.290199869956178,PMM1;GMPPA
GO_Biological_Process_2021,Sphingolipid signaling pathway,5/119,0.7198888393511147,0.9999956780977234,0,0,0.8281140350877193,0.2721666906655753,MAPK11;SGMS1;MAPK1;PLD1;MAP3K5
GO_Biological_Process_2021,Cholesterol metabolism,2/50,0.7235473266236062,0.9999956780977234,0,0,0.7870970422067132,0.254696197929134,VAPB;VDAC2
GO_Biological_Process_2021,Spinocerebellar ataxia,6/143,0.7301367451136518,0.9999956780977234,0,0,0.8267245347537319,0.2600242448584305,SEM1;PPIF;VDAC2;ITPR2;MAP3K5;SLC25A6
GO_Biological_Process_2021,Thyroid hormone signaling pathway,5/121,0.7333370333484802,0.9999956780977234,0,0,0.81375,0.2523844671621628,KAT2B;MAPK1;SLC16A10;ESR1;MED12L
GO_Biological_Process_2021,Folate biosynthesis,1/26,0.7385011771050013,0.9999956780977234,0,0,0.7557768924302789,0.2291006016486483,PAH
GO_Biological_Process_2021,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/26,0.7385011771050013,0.9999956780977234,0,0,0.7557768924302789,0.2291006016486483,PIGO
GO_Biological_Process_2021,Maturity onset diabetes of the young,1/26,0.7385011771050013,0.9999956780977234,0,0,0.7557768924302789,0.2291006016486483,ONECUT1
GO_Biological_Process_2021,Chronic myeloid leukemia,3/76,0.7421879110018805,0.9999956780977234,0,0,0.776064309736691,0.2313857613227158,TGFB1;ABL1;MAPK1
GO_Biological_Process_2021,Pertussis,3/76,0.7421879110018805,0.9999956780977234,0,0,0.776064309736691,0.2313857613227158,MAPK11;JUN;MAPK1
GO_Biological_Process_2021,AGE-RAGE signaling pathway in diabetic complications,4/100,0.7464021678822493,0.9999956780977234,0,0,0.7866716616716617,0.2300941646610219,MAPK11;JUN;TGFB1;MAPK1
GO_Biological_Process_2021,Biosynthesis of unsaturated fatty acids,1/27,0.751658525248718,0.9999956780977234,0,0,0.7266702421084891,0.2074448407927877,SCD5
GO_Biological_Process_2021,Glycosaminoglycan biosynthesis,2/53,0.752915270294675,0.9999956780977234,0,0,0.74067992102125,0.2102068728084875,DSE;HS6ST3
GO_Biological_Process_2021,Synaptic vesicle cycle,3/78,0.757942279705911,0.9999956780977234,0,0,0.7552894211576846,0.2093269860180919,NAPA;RIMS1;AP2A1
GO_Biological_Process_2021,Pancreatic secretion,4/102,0.7601541195587337,0.9999956780977234,0,0,0.7705355868621174,0.2113071157420179,CHRM3;CPA1;ITPR2;RAB11A
GO_Biological_Process_2021,cAMP signaling pathway,9/216,0.7630055575480967,0.9999956780977234,0,0,0.8201501658809149,0.2218423887722128,VAV3;CREB3;JUN;CREB3L1;PDE4D;PDE4B;MAPK1;CACNA1C;PLD1
GO_Biological_Process_2021,Osteoclast differentiation,5/127,0.7708417472654767,0.9999956780977234,0,0,0.773483606557377,0.201316266756127,MAPK11;JUN;TGFB1;IFNGR2;MAPK1
GO_Biological_Process_2021,C-type lectin receptor signaling pathway,4/104,0.7733204217215267,0.9999956780977234,0,0,0.7550449550449551,0.1940932146048996,MAPK11;JUN;ITPR2;MAPK1
GO_Biological_Process_2021,T cell receptor signaling pathway,4/104,0.7733204217215267,0.9999956780977234,0,0,0.7550449550449551,0.1940932146048996,VAV3;MAPK11;JUN;MAPK1
GO_Biological_Process_2021,Hedgehog signaling pathway,2/56,0.7795529058265748,0.9999956780977234,0,0,0.6994202577452827,0.1741799289572945,EVC;BTRC
GO_Biological_Process_2021,Pyrimidine metabolism,2/56,0.7795529058265748,0.9999956780977234,0,0,0.6994202577452827,0.1741799289572945,DPYD;NME3
GO_Biological_Process_2021,B cell receptor signaling pathway,3/81,0.7801043821053218,0.9999956780977234,0,0,0.7261246737294641,0.1803167576202638,VAV3;JUN;MAPK1
GO_Biological_Process_2021,Peroxisome,3/82,0.7871102530274168,0.9999956780977234,0,0,0.7168953232774956,0.1716153831771244,GSTK1;PIPOX;PEX1
GO_Biological_Process_2021,Ascorbate and aldarate metabolism,1/30,0.787293406766121,0.9999956780977234,0,0,0.651394422310757,0.1557837662225422,AKR1A1
GO_Biological_Process_2021,beta-Alanine metabolism,1/30,0.787293406766121,0.9999956780977234,0,0,0.651394422310757,0.1557837662225422,DPYD
GO_Biological_Process_2021,mTOR signaling pathway,6/154,0.7917634676607159,0.9999956780977234,0,0,0.764832399967535,0.1785826931786066,RRAGA;IRS1;DVL1;MAPK1;RICTOR;SGK1
GO_Biological_Process_2021,Glucagon signaling pathway,4/107,0.7919943238114381,0.9999956780977234,0,0,0.7329369659466747,0.1709216730462596,CREB3;CREB3L1;ITPR2;ACACA
GO_Biological_Process_2021,Endometrial cancer,2/58,0.7958824201275414,0.9999956780977234,0,0,0.6743697478991597,0.1539611878222624,TCF7L1;MAPK1
GO_Biological_Process_2021,Circadian rhythm,1/31,0.7979978926127523,0.9999956780977234,0,0,0.6296480743691899,0.1420796613142204,BTRC
GO_Biological_Process_2021,VEGF signaling pathway,2/59,0.803638824675323,0.9999956780977234,0,0,0.6625037169194172,0.1448268461641565,MAPK11;MAPK1
GO_Biological_Process_2021,Vascular smooth muscle contraction,5/133,0.8041853221846622,0.9999956780977234,0,0,0.7369921875,0.1606094175879401,CALCRL;ITPR2;MAPK1;CACNA1C;ADRA1A
GO_Biological_Process_2021,Complement and coagulation cascades,3/85,0.8070230288700456,0.9999956780977234,0,0,0.6905579085730977,0.1480577388738997,F13A1;A2M;CLU
GO_Biological_Process_2021,Necroptosis,6/159,0.8159565555306209,0.9999956780977234,0,0,0.7396416023867004,0.1504387870092069,H2AZ1;FTH1;IFNGR2;VDAC2;FTL;SLC25A6
GO_Biological_Process_2021,SNARE interactions in vesicular transport,1/33,0.8178192967361426,0.9999956780977234,0,0,0.5902328187250996,0.1187040095731781,VTI1A
GO_Biological_Process_2021,Arachidonic acid metabolism,2/61,0.818369069478635,0.9999956780977234,0,0,0.6399783699748213,0.1282784541662566,ALOX5;CBR3
GO_Biological_Process_2021,Glycerolipid metabolism,2/61,0.818369069478635,0.9999956780977234,0,0,0.6399783699748213,0.1282784541662566,DGKB;AKR1A1
GO_Biological_Process_2021,Apelin signaling pathway,5/137,0.8241980161622214,0.9999956780977234,0,0,0.7145075757575757,0.1381460864496228,GABARAPL2;MEF2C;TFAM;ITPR2;MAPK1
GO_Biological_Process_2021,Insulin signaling pathway,5/137,0.8241980161622214,0.9999956780977234,0,0,0.7145075757575757,0.1381460864496228,IRS1;FLOT1;TRIP10;MAPK1;ACACA
GO_Biological_Process_2021,Yersinia infection,5/137,0.8241980161622214,0.9999956780977234,0,0,0.7145075757575757,0.1381460864496228,VAV3;MAPK11;JUN;ITGA4;MAPK1
GO_Biological_Process_2021,Propanoate metabolism,1/34,0.8269889263176455,0.9999956780977234,0,0,0.5723167934323313,0.1087195726003037,ACACA
GO_Biological_Process_2021,Hepatitis B,6/162,0.8293763701705514,0.9999956780977234,0,0,0.7253022253022253,0.1356904265165258,CREB3;MAPK11;JUN;TGFB1;CREB3L1;MAPK1
GO_Biological_Process_2021,Alcoholism,7/186,0.831159895168865,0.9999956780977234,0,0,0.7372958206916627,0.1363503941262753,H2AZ1;CREB3;CREB3L1;MAPK1;H4C3;HDAC9;HDAC6
GO_Biological_Process_2021,Basal cell carcinoma,2/63,0.8321012928430873,0.9999956780977234,0,0,0.6189300949610186,0.113760031884391,TCF7L1;DVL1
GO_Biological_Process_2021,Cytosolic DNA-sensing pathway,2/63,0.8321012928430873,0.9999956780977234,0,0,0.6189300949610186,0.113760031884391,POLR3D;POLR3H
GO_Biological_Process_2021,Rap1 signaling pathway,8/210,0.8337645119888805,0.9999956780977234,0,0,0.746516778056943,0.1357199425207036,VAV3;MAPK11;PDGFC;MAGI2;MAPK1;TLN2;RAP1GAP;PFN2
GO_Biological_Process_2021,DNA replication,1/36,0.8439680488320506,0.9999956780977234,0,0,0.5395560614684121,0.0915306366284098,RPA1
GO_Biological_Process_2021,Mucin type O-glycan biosynthesis,1/36,0.8439680488320506,0.9999956780977234,0,0,0.5395560614684121,0.0915306366284098,GALNT7
GO_Biological_Process_2021,Starch and sucrose metabolism,1/36,0.8439680488320506,0.9999956780977234,0,0,0.5395560614684121,0.0915306366284098,TREH
GO_Biological_Process_2021,Small cell lung cancer,3/92,0.8474374781423939,0.9999956780977234,0,0,0.6360088811141762,0.1052837746189813,MAX;LAMA3;FHIT
GO_Biological_Process_2021,Aminoacyl-tRNA biosynthesis,2/66,0.8509460700154076,0.9999956780977234,0,0,0.5898242771684945,0.0952014868804333,NARS1;FARS2
GO_Biological_Process_2021,Signaling pathways regulating pluripotency of stem cells,5/143,0.85108017188366,0.9999956780977234,0,0,0.6832246376811594,0.1101692525824097,MAPK11;DVL1;ESRRB;ONECUT1;MAPK1
GO_Biological_Process_2021,Salivary secretion,3/93,0.8525669393187819,0.9999956780977234,0,0,0.6289088489687292,0.1003131951136437,CHRM3;ITPR2;ADRA1A
GO_Biological_Process_2021,Transcriptional misregulation in cancer,7/192,0.854050055389739,0.9999956780977234,0,0,0.7131560418133565,0.1125114010030908,MEF2C;DDX5;MAX;MLLT3;ETV4;PBX1;BAIAP3
GO_Biological_Process_2021,Acute myeloid leukemia,2/67,0.8567864507093924,0.9999956780977234,0,0,0.5807193803205767,0.0897598049582442,TCF7L1;MAPK1
GO_Biological_Process_2021,Breast cancer,5/147,0.8670356568782778,0.9999956780977234,0,0,0.663838028169014,0.0947132077125483,JUN;TCF7L1;DVL1;MAPK1;ESR1
GO_Biological_Process_2021,Renin secretion,2/69,0.8678440009193724,0.9999956780977234,0,0,0.5633249505215696,0.0798475391024376,ITPR2;CACNA1C
GO_Biological_Process_2021,Influenza A,6/172,0.8685278729238407,0.9999956780977234,0,0,0.6812475125728138,0.0960256523187942,IFNGR2;MX1;TRIM25;MAPK1;RAB11A;SLC25A6
GO_Biological_Process_2021,Circadian entrainment,3/97,0.8716065901441823,0.9999956780977234,0,0,0.6020193655242706,0.0827277643646835,KCNJ6;MAPK1;CACNA1C
GO_Biological_Process_2021,Fc gamma R-mediated phagocytosis,3/97,0.8716065901441823,0.9999956780977234,0,0,0.6020193655242706,0.0827277643646835,VAV3;MAPK1;PLD1
GO_Biological_Process_2021,Phosphatidylinositol signaling system,3/97,0.8716065901441823,0.9999956780977234,0,0,0.6020193655242706,0.0827277643646835,SYNJ1;DGKB;ITPR2
GO_Biological_Process_2021,"Glycine, serine and threonine metabolism",1/40,0.8730948713410943,0.9999956780977234,0,0,0.4841148227602411,0.0656997339489972,PIPOX
GO_Biological_Process_2021,Nicotine addiction,1/40,0.8730948713410943,0.9999956780977234,0,0,0.4841148227602411,0.0656997339489972,GABRG1
GO_Biological_Process_2021,Cell cycle,4/124,0.8755531456392238,0.9999956780977234,0,0,0.6285381285381285,0.0835323564469792,TGFB1;ABL1;SMC1A;ATR
GO_Biological_Process_2021,Platelet activation,4/124,0.8755531456392238,0.9999956780977234,0,0,0.6285381285381285,0.0835323564469792,MAPK11;ITPR2;MAPK1;TLN2
GO_Biological_Process_2021,Adherens junction,2/71,0.8781121822724376,0.9999956780977234,0,0,0.546938893464534,0.0710916223431439,TCF7L1;MAPK1
GO_Biological_Process_2021,Melanoma,2/72,0.8829654413926015,0.9999956780977234,0,0,0.5390969947300954,0.0671009807482226,PDGFC;MAPK1
GO_Biological_Process_2021,Non-small cell lung cancer,2/72,0.8829654413926015,0.9999956780977234,0,0,0.5390969947300954,0.0671009807482226,MAPK1;FHIT
GO_Biological_Process_2021,Tryptophan metabolism,1/42,0.8855527963796259,0.9999956780977234,0,0,0.4604508794091925,0.055964673462482,ACMSD
GO_Biological_Process_2021,Inositol phosphate metabolism,2/73,0.8876393449048766,0.9999956780977234,0,0,0.5314759945515566,0.0633464970939314,SYNJ1;PLCH1
GO_Biological_Process_2021,p53 signaling pathway,2/73,0.8876393449048766,0.9999956780977234,0,0,0.5314759945515566,0.0633464970939314,AIFM2;ATR
GO_Biological_Process_2021,Lysosome,4/128,0.8903730765885075,0.9999956780977234,0,0,0.6081338016821888,0.0706132842270996,CD63;CTSL;M6PR;CTSV
GO_Biological_Process_2021,Fatty acid degradation,1/43,0.8913157797483712,0.9999956780977234,0,0,0.4494640485676342,0.0517137620155326,ACADVL
GO_Biological_Process_2021,Porphyrin and chlorophyll metabolism,1/43,0.8913157797483712,0.9999956780977234,0,0,0.4494640485676342,0.0517137620155326,CP
GO_Biological_Process_2021,Amoebiasis,3/102,0.8923261899968872,0.9999956780977234,0,0,0.5714631343373858,0.0651030971829351,ARG2;TGFB1;LAMA3
GO_Biological_Process_2021,Longevity regulating pathway,3/102,0.8923261899968872,0.9999956780977234,0,0,0.5714631343373858,0.0651030971829351,CREB3;IRS1;CREB3L1
GO_Biological_Process_2021,Glioma,2/75,0.8964719526672191,0.9999956780977234,0,0,0.5168603777707972,0.0564867774457563,MAPK1;CAMK1
GO_Biological_Process_2021,Toll-like receptor signaling pathway,3/104,0.899738328700058,0.9999956780977234,0,0,0.5600877453014762,0.0591740005455065,MAPK11;JUN;MAPK1
GO_Biological_Process_2021,Gastric acid secretion,2/76,0.9006417784434997,0.9999956780977234,0,0,0.5098488318827302,0.0533544987451976,CHRM3;ITPR2
GO_Biological_Process_2021,PI3K-Akt signaling pathway,13/354,0.908051810893422,0.9999956780977234,0,0,0.7168846372150223,0.0691462772100181,ITGA4;IRS1;MAGI2;LAMA3;TNC;CREB3;ERBB4;CREB3L1;CDC37;PDGFC;MAPK1;COL9A3;SGK1
GO_Biological_Process_2021,Nucleotide excision repair,1/47,0.9116105482083092,0.9999956780977234,0,0,0.4102936081759917,0.0379695595480714,RPA1
GO_Biological_Process_2021,RNA degradation,2/79,0.9122293934634648,0.9999956780977234,0,0,0.4899069026686175,0.045004706107497,LSM5;PATL1
GO_Biological_Process_2021,Insulin resistance,3/108,0.9131975094373914,0.9999956780977234,0,0,0.5386370116909039,0.0489099059234226,CREB3;IRS1;CREB3L1
GO_Biological_Process_2021,"Valine, leucine and isoleucine degradation",1/48,0.916062484041812,0.9999956780977234,0,0,0.4015427651097736,0.0352035363471565,BCAT2
GO_Biological_Process_2021,HIF-1 signaling pathway,3/109,0.9162952441718606,0.9999956780977234,0,0,0.5335272850525364,0.0466391664899286,IFNGR2;MAPK1;ELOB
GO_Biological_Process_2021,Hippo signaling pathway,5/163,0.9171554445408864,0.9999956780977234,0,0,0.5961075949367088,0.0515503755226736,MOB1B;TCF7L1;TGFB1;DVL1;BTRC
GO_Biological_Process_2021,Ether lipid metabolism,1/49,0.9202903939957282,0.9999956780977234,0,0,0.3931565405046481,0.0326579463427804,PLD1
GO_Biological_Process_2021,Arginine and proline metabolism,1/50,0.9243055406949924,0.9999956780977234,0,0,0.3851126107813643,0.0303132111334958,ARG2
GO_Biological_Process_2021,Malaria,1/50,0.9243055406949924,0.9999956780977234,0,0,0.3851126107813643,0.0303132111334958,TGFB1
GO_Biological_Process_2021,Regulation of actin cytoskeleton,7/218,0.9258488038947555,0.9999956780977234,0,0,0.6244147061896305,0.0481076166759982,VAV3;CHRM3;ITGA4;PDGFC;MAPK1;PFN2;ARHGEF6
GO_Biological_Process_2021,Ubiquitin mediated proteolysis,4/140,0.925944017602824,0.9999956780977234,0,0,0.5541223482399953,0.0426350059404342,FBXW7;ELOB;BTRC;RPS27A
GO_Biological_Process_2021,Ovarian steroidogenesis,1/51,0.928118620746998,0.9999956780977234,0,0,0.3773904382470119,0.0281517153432049,ALOX5
GO_Biological_Process_2021,MAPK signaling pathway,10/294,0.9290973183855318,0.9999956780977234,0,0,0.6621487720291599,0.0486956056689167,MAPK11;MEF2C;JUN;TGFB1;MAX;ERBB4;PDGFC;MAPK1;CACNA1C;MAP3K5
GO_Biological_Process_2021,Leukocyte transendothelial migration,3/114,0.9303231657792392,0.9999956780977234,0,0,0.5093596590602578,0.0367876166740964,VAV3;MAPK11;ITGA4
GO_Biological_Process_2021,Taste transduction,2/86,0.9345207794234008,0.9999956780977234,0,0,0.4489151592840526,0.030401170457372,CHRM3;CACNA1C
GO_Biological_Process_2021,Protein processing in endoplasmic reticulum,5/171,0.9353148139236256,0.9999956780977234,0,0,0.5671385542168674,0.0379257500703056,SELENOS;DERL2;SEL1L2;SEC24D;MAP3K5
GO_Biological_Process_2021,Regulation of lipolysis in adipocytes,1/55,0.941545964694254,0.9999956780977234,0,0,0.3493618120112144,0.0210427995698668,IRS1
GO_Biological_Process_2021,Phospholipase D signaling pathway,4/148,0.9434981398610832,0.9999956780977234,0,0,0.5231157731157731,0.0304248766911185,DGKB;PDGFC;MAPK1;PLD1
GO_Biological_Process_2021,Gastric cancer,4/149,0.9454026886123452,0.9999956780977234,0,0,0.5194805194805194,0.0291658788251317,TCF7L1;TGFB1;DVL1;MAPK1
GO_Biological_Process_2021,Herpes simplex virus 1 infection,18/498,0.9468023170211102,0.9999956780977234,0,0,0.7034574468085106,0.0384544690639314,ZNF790;EIF2B2;IFNGR2;HLA-B;HLA-C;ZNF98;HLA-A;HLA-F;ZNF81;ZNF568;ZNF546;SRSF5;ZNF610;SRSF7;B2M;ZNF124;ZNF761;ZNF189
GO_Biological_Process_2021,Tuberculosis,5/180,0.9514136960375268,0.9999956780977234,0,0,0.5377142857142857,0.0267815587170373,MAPK11;TGFB1;IFNGR2;NFYC;MAPK1
GO_Biological_Process_2021,TGF-beta signaling pathway,2/94,0.9534140998677048,0.9999956780977234,0,0,0.40970566561186,0.0195453968856141,TGFB1;MAPK1
GO_Biological_Process_2021,Pathways in cancer,19/531,0.9560431908900456,0.9999956780977234,0,0,0.6956314179766734,0.0312701544159288,GSTM4;GSTM2;JUN;TCF7L1;TGFB1;GSTO1;MAX;IL15;DCC;DAPK2;IFNGR2;LAMA3;GSTT2;PLD1;ESR1;DVL1;ABL1;MAPK1;ELOB
GO_Biological_Process_2021,Glycerophospholipid metabolism,2/98,0.9607838476811666,0.9999956780977234,0,0,0.3925515121302758,0.0157043450095355,DGKB;PLD1
GO_Biological_Process_2021,Inflammatory mediator regulation of TRP channels,2/98,0.9607838476811666,0.9999956780977234,0,0,0.3925515121302758,0.0157043450095355,MAPK11;ITPR2
GO_Biological_Process_2021,mRNA surveillance pathway,2/98,0.9607838476811666,0.9999956780977234,0,0,0.3925515121302758,0.0157043450095355,PNN;RBM8A
GO_Biological_Process_2021,Lysine degradation,1/63,0.9613492668276334,0.9999956780977234,0,0,0.3041543503405732,0.0119890025876778,PIPOX
GO_Biological_Process_2021,Lipid and atherosclerosis,6/215,0.9621907761277008,0.9999956780977234,0,0,0.5398508556403293,0.0208072210352306,VAV3;MAPK11;JUN;MAPK1;MIB1;MAP3K5
GO_Biological_Process_2021,Hematopoietic cell lineage,2/99,0.9624435933811764,0.9999956780977234,0,0,0.3884840324387661,0.014871098374973,ITGA4;CD44
GO_Biological_Process_2021,Glycolysis / Gluconeogenesis,1/67,0.9685729722201648,0.9999956780977234,0,0,0.2856603887480382,0.0091215513820058,AKR1A1
GO_Biological_Process_2021,NF-kappa B signaling pathway,2/104,0.9697792868606572,0.9999956780977234,0,0,0.3693429515375442,0.0113339432001915,TRIM25;TAB3
GO_Biological_Process_2021,Retinol metabolism,1/68,0.9701573740840508,0.9999956780977234,0,0,0.28138193494678,0.0085250226642856,BCO1
GO_Biological_Process_2021,Adipocytokine signaling pathway,1/69,0.971661966781686,0.9999956780977234,0,0,0.2772293180220295,0.0079695959843225,IRS1
GO_Biological_Process_2021,Tight junction,4/169,0.9730402354555896,0.9999956780977234,0,0,0.4560288196651833,0.0124631972728427,JUN;ARHGEF18;MAP3K5;TUBA8
GO_Biological_Process_2021,Central carbon metabolism in cancer,1/70,0.9730907667553396,0.9999956780977234,0,0,0.2731970668052428,0.0074522465534606,MAPK1
GO_Biological_Process_2021,Measles,3/139,0.973184485350039,0.9999956780977234,0,0,0.4151769989432899,0.0112851793046623,JUN;MX1;EIF3H
GO_Biological_Process_2021,PPAR signaling pathway,1/74,0.97812150643112,0.9999956780977234,0,0,0.2581727882988593,0.0057111375707245,SCD5
GO_Biological_Process_2021,Bacterial invasion of epithelial cells,1/77,0.9812675845411412,0.9999956780977234,0,0,0.2479424407632627,0.0046886137443449,SEPTIN6
GO_Biological_Process_2021,Hepatitis C,3/157,0.986940404348016,0.9999956780977234,0,0,0.3662998677968738,0.0048152395902382,MX1;MAPK1;IFIT1
GO_Biological_Process_2021,Systemic lupus erythematosus,2/135,0.9924065862053124,0.9999956780977234,0,0,0.2827907255676579,0.0021555413521325,H2AZ1;H4C3
GO_Biological_Process_2021,Neuroactive ligand-receptor interaction,8/341,0.9959962164696946,0.9999956780977234,0,0,0.4496853925138779,0.0018040569098362,CHRM3;GRID2;CALCRL;GALR1;GRIK2;OPRM1;ADRA1A;GABRG1
GO_Biological_Process_2021,Ras signaling pathway,4/232,0.9975886697133364,0.9999956780977234,0,0,0.32891669733775,0.000794084579410766,PDGFC;ABL1;MAPK1;PLD1
GO_Biological_Process_2021,JAK-STAT signaling pathway,2/162,0.997799548651866,0.9999956780977234,0,0,0.2347333000997009,0.0005170883293864912,IL15;IFNGR2
GO_Biological_Process_2021,MicroRNAs in cancer,6/310,0.9985511003528864,0.9999956780977234,0,0,0.3692705863758495,0.0005354240038508157,MMP16;IRS1;TNC;ABL1;MAPK1;CD44
GO_Biological_Process_2021,Chemokine signaling pathway,2/192,0.9994580245228932,0.9999956780977234,0,0,0.1973553025135121,0.00010699073003493184,VAV3;MAPK1
GO_Biological_Process_2021,Cytokine-cytokine receptor interaction,3/295,0.9999648396242004,0.9999956780977234,0,0,0.1917705684521368,6.742843795223469e-06,TGFB1;IL15;IFNGR2
GO_Biological_Process_2021,Olfactory transduction,1/440,0.9999956780977234,0.9999956780977234,0,0,0.0421003911461216,1.819541695352049e-07,OR2L3
